Jul 2026
Computational structure-based screening identifies potential inhibitors of TRIM33α
The identified compounds may serve as valuable starting points for further experimental validation and structural optimization toward the development of novel anticancer agents targeting TRIM33, and establishes a robust computational framework for developing TRIM33α-targeted therapies.
Yingying Jiang, Hongwei Gao, Siyuan Wang et al.
· Genome Instability & Disease · 0 citations